Jury hits Wright Medical with $11m verdict in Conserve hip implant bellwether
A federal jury in Georgia last week handed an $11 million loss to Wright Medical (NSDQ:WMGI) in the 1st bellwether trial in the multidistrict litigation filed over its Conserve metal-on-metal hip...
View ArticleJohnson & Johnson escapes DePuy Pinnacle hip implant lawsuit
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics yesterday won the dismissal of a False Claims Act lawsuit brought by a pair of British surgeons over its since-discontinued Pinnacle...
View ArticleFDA mandates PMAs for metal-on-metal hip implants
The FDA said today that it will require the manufacturers of metal-on-metal hip implants to put the devices through its stringent pre-market approval process. The federal safety watchdog said its final...
View ArticleJury slaps Johnson & Johnson with $500m verdict in Pinnacle hip bellwether
UPDATED March 18, 2016, with additional comment from DePuy, plaintiffs’ and defendant’s attorneys. A Texas federal jury today slapped Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics with...
View ArticleStudy: Metal-on-metal hips impede osteoblast formation
A study of metal-on-metal hip implants found that the metal ions released when the parts of the cobalt-chromium-molybdenum devices rub against each other were able to penetrate into bone marrow, where...
View ArticleJohnson & Johnson wants Pinnacle bellwethers stayed after $500m loss
A Johnson & Johnson (NYSE:JNJ) subsidiary wants a federal appeals court to hit the pause button in the multi-district litigation over its Pinnacle metal-on-metal hip implant to give it enough time...
View ArticleWright Medical wants retrial in Conserve hip implant loss
Wright Medical (NSDQ:WMGI) wants a federal appeals court to overturn the verdict in the 1st bellwether trial over its Conserve metal-on-metal hip implant, arguing that a new trial is warranted because...
View ArticleJudge slashes $500m jury verdict to $151m in J&J’s Pinnacle hip loss
A federal judge yesterday slashed a $500 million verdict against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics in the multi-district litigation over its Pinnacle metal-on-metal hip...
View ArticleJohnson & Johnson’s DePuy wants expedited appeal of $151m Pinnacle hip loss
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics asked a federal appeals court this week to expedite the appeal of its $151 million loss in a product liability lawsuit brought over its...
View ArticlePlaintiff’s $8m win in DePuy ASR hip trial survives Johnson & Johnson’s appeal
An $8 million plaintiff’s award in a product liability lawsuit brought over the DePuy ASR XL metal-on-metal hip implant made by Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics survived...
View ArticleJury levels $1B verdict against J&J’s DePuy Ortho in Pinnacle hip bellwether
UPDATED Dec. 2, 2016, with quotes from plaintiff’s and defense attorneys and DePuy Orthopedics. A federal jury in Dallas today ordered Johnson & Johnson (NYSE:JNJ) and its subsidiary DePuy...
View ArticleStryker reaches new metal-on-metal hip implant settlement deal
Stryker (NYSE:SYK) said today that it, and its Howmedica Osteonics subsidiary have reached a compensation agreement for patients who had revision surgery to correct issues with its recalled Rejuvenate...
View ArticleStryker Q4 earnings take hit from recalled hip implants
Stryker’s profits decreased 2.3% year-over-year in the fourth quarter, to $510 million, amid charges related to its recalled Rejuvenate or ABG II modular metal-on-metal neck hip stems, as well as...
View ArticleJohnson & Johnson seeks new trials after $1B Pinnacle hip implant loss
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics wants a federal judge to grant new trials after it lost a $1 billion judgment to 6 plaintiffs who sued over its metal-on-metal Pinnacle...
View ArticleFailure to thrive: Lessons learned from medtech innovations that missed the mark
Some of the medical device industry’s most heralded disruptors wound up being its biggest failures. Here’s what we can learn from their mistakes. Fink Densford, Associate Editor No one in medtech sets...
View ArticleStryker hits enrollment milestone in 2nd metal-on-metal hip implant settlement
Stryker (NYSE:SYK) said today that it hit a milestone in the 2nd round of settlements for the Rejuvenate or ABG II modular metal-on-metal neck hip stems made by its Howmedica Osteonics subsidiary, with...
View ArticleJ&J loses bid to stay FCA verdict
Earlier this week, the U.S. First Circuit Court of Appeals denied Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopedics’ bid to stay a decision reviving a False Claims Act suit over its...
View ArticleTampering allegations in Johnson & Johnson hip case prompt judge to trigger...
A federal judge in Texas this week took the unusual step of asking federal prosecutors and the FBI to probe possible witness tampering by lawyers for Johnson & Johnson (NYSE:JNJ) in a bellwether...
View ArticleJohnson & Johnson lawyers deny tampering allegations in hip case
Lawyers for Johnson & Johnson(NYSE:JNJ) in a bellwether trial over metal-on-metal hip implants made by J&J subsidiary DePuy Orthopaedics yesterday denied witness tampering allegations leveled...
View ArticleReport: India eyes penalties for Johnson & Johnson over metal-on-metal hips
Johnson & Johnson (NYSE:JNJ) could reportedly be on the hook again for the metal-on-metal hip implants it pulled from the market in 2010, this time in India and for much less than it’s cost the...
View ArticleReport: Justice Dept. closes tampering probe in Johnson & Johnson hip case
The U.S. Justice Dept. reportedly closed its probe into alleged witness tampering in a bellwether trial over the Pinnacle metal-on-metal hip implants made by Johnson & Johnson (NYSE:JNJ) subsidiary...
View ArticleWright Medical, plaintiffs extend deadline for $90m metal-on-metal hip...
Balky insurance companies delayed a final settlement between Wright Medical (NSDQ:WMGI) and the plaintiffs in product liability lawsuits brought over its metal-on-metal hip implants, according to a...
View ArticleNetflix’s ‘The Bleeding Edge’ blasts medtech & FDA
Essure activist Angie Firmalino discusses surgeries with a nurse in Netflix’s ‘The Bleeding Edge.’ Netflix has unleashed a blistering indictment of the medical device industry, the FDA and doctors who...
View ArticleStryker, plaintiffs to settle hip implant cases
A Massachusetts federal judge last week stayed the multi-district litigation brought over hip implants made by Stryker (NYSE:SYK) so that the company and lawyers representing thousands of plaintiffs...
View ArticleIs the medical device industry endangering people?
(Image from Unsplash) The highly critical “Implant Files” report overseen by the International Consortium of Investigative Journalists skewers the medtech industry as a whole and singles out particular...
View Article